Literature DB >> 33242614

Aortic Regurgitation Index Ratio Is a Strong Predictor of 1-Year Mortality After Transcatheter Aortic Valve Implantation Using Self-Expanding Devices.

Marleen van Wely1, Kees van der Wulp1, Max Rooijakkers1, Priya Vart2, Wim Morshuis3, Niels van Royen4, Helmut Gehlmann1, Michel Verkroost3, Peter Kievit1, Leen van Garsse5, Guillaume Geuzebroek5.   

Abstract

Grading paravalvular leak (PVL) at the time of transcatheter aortic valve implantation (TAVI) deployment is challenging. Per-procedural invasive hemodynamic measurements could serve to optimize PVL grading and predict outcome after TAVI. The aim of this study was to compare hemodynamic measures of paravalvular leak and their prognostic relevance in self-expanding TAVI devices. Between December 2008 and December 2017 consecutive patients treated for severe symptomatic aortic valve stenosis with self-expanding devices were prospectively studied. Peri-procedural hemodynamic measurements, echocardiographic data as well as clinical follow-up according to VARC-2 criteria were prospectively collected. Diastolic delta (DD), heart rate adjusted DD, aortic regurgitation index (ARI) and ARI ratio were calculated and assessed for their association with 1-year mortality. A total of 651 patients were studied. Moderate or severe paravalvular leakage was found in 4.8% of patients. ARI ratio < 0.6 (hazard ratio 1.96 [1.23-3.12], P = 0.005) was the best independent predictor of 1-year mortality. This study confirms the value of hemodynamic measures, specifically ARI ratio, for prognostication, potentially supporting procedural decision-making with regard to PVL.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hemodynamic measures; Paravalvular leak; TAVI

Mesh:

Year:  2020        PMID: 33242614     DOI: 10.1053/j.semtcvs.2020.11.025

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  1 in total

1.  Reduction of Gastrointestinal Bleeding in Patients With Heyde Syndrome Undergoing Transcatheter Aortic Valve Implantation.

Authors:  Lia C M J Goltstein; Maxim J P Rooijakkers; Natasha C C Görtjes; Reinier P Akkermans; Erwin S Zegers; Ron Pisters; Marleen H van Wely; Kees van der Wulp; Joost P H Drenth; Erwin J M van Geenen; Niels van Royen
Journal:  Circ Cardiovasc Interv       Date:  2022-07-05       Impact factor: 7.514

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.